Celularity Inc (CELU) USD0.0001 A

Sell:$1.52Buy:$1.55$0.04 (2.23%)

Prices delayed by at least 15 minutes
Sell:$1.52
Buy:$1.55
Change:$0.04 (2.23%)
Deal now
Prices delayed by at least 15 minutes
Sell:$1.52
Buy:$1.55
Change:$0.04 (2.23%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).

Key people

Robert J. Hariri
Chairman of the Board, Chief Executive Officer
David C. Beers
Chief Financial Officer
Stephen A. Brigido
President - Degenerative Disease
John R. Haines
Senior Executive Vice President, Chief Administrative Officer, General Manager
K. Harold Fletcher
Executive Vice President, General Counsel
Shiu Fei Ling
Director
Richard J. Berman
Independent Director
Peter H. Diamandis
Independent Director
Dean C. Kehler
Independent Director
Diane L. Parks
Independent Director
Click to see more

Key facts

  • EPIC
    CELU
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1511902041
  • Market cap
    $30.13m
  • Employees
    120
  • Shares in issue
    22.48m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.